• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Analysis of cancer immune regulation mechanism by new immune checkpoint molecule Clec4A4

Research Project

Project/Area Number 17K15027
Research Category

Grant-in-Aid for Young Scientists (B)

Allocation TypeMulti-year Fund
Research Field Tumor therapeutics
Research InstitutionUniversity of Miyazaki

Principal Investigator

UTO Tomofumi  宮崎大学, 医学部, 講師 (10624653)

Project Period (FY) 2017-04-01 – 2020-03-31
Project Status Completed (Fiscal Year 2019)
Budget Amount *help
¥4,420,000 (Direct Cost: ¥3,400,000、Indirect Cost: ¥1,020,000)
Fiscal Year 2019: ¥1,560,000 (Direct Cost: ¥1,200,000、Indirect Cost: ¥360,000)
Fiscal Year 2018: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Fiscal Year 2017: ¥1,430,000 (Direct Cost: ¥1,100,000、Indirect Cost: ¥330,000)
Keywords腫瘍治療学 / 免疫抑制 / 樹状細胞 / 免疫学
Outline of Final Research Achievements

In this study, I focused on Clec4A4 molecule, which is involved in suppression of immune response during cancer progression, and attempted functional identification of a novel dendritic cell immune checkpoint that negatively regulates cancer immune responses. As a result, tumor progression of melanoma was suppressed in the tumor-bearing Clec4A4 deficient mice as compared with the tumor-bearing wild type mice. This result suggest that Clec4A4 functions as an activation regulatory molecule of dendritic cells and is a new immune checkpoint in the cancer immune responses.

Academic Significance and Societal Importance of the Research Achievements

現在、免疫チェックポイント分子として判明しているものは主としてT細胞発現分子であり、樹状細胞の機能に着目した報告は皆無であることから、新規樹状細胞発現免疫チェックポイント分子の発見は学術的にも社会的にも大きな意義がある。将来の展望として、マウスClec4A4分子のヒトに相当する分子に対する機能阻害抗体の作出等が、新たながん免疫療法に繋がることが強く期待される。

Report

(4 results)
  • 2019 Annual Research Report   Final Research Report ( PDF )
  • 2018 Research-status Report
  • 2017 Research-status Report
  • Research Products

    (2 results)

All 2019 2018

All Presentation (1 results) Patent(Industrial Property Rights) (1 results)

  • [Presentation] Critical role of plasmacytoid dendritic cells in establishing oral tolerance leading to abortive allergic sensitization2018

    • Author(s)
      宇都倫史、高木秀明、深谷知宏、奈須遵太、福井丈仁、宮永宜明、佐藤克明
    • Organizer
      第47回日本免疫学会総会
    • Related Report
      2018 Research-status Report
  • [Patent(Industrial Property Rights)] 免疫チェックポイント阻害剤2019

    • Inventor(s)
      佐藤 克明
    • Industrial Property Rights Holder
      佐藤 克明
    • Industrial Property Rights Type
      特許
    • Industrial Property Number
      2018-095752
    • Filing Date
      2019
    • Related Report
      2019 Annual Research Report 2018 Research-status Report

URL: 

Published: 2017-04-28   Modified: 2024-01-30  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi